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Background
Food allergic patients at risk for severe reactions should
carry an epinephrine auto-injector (EAI). This treatment
entails a burden for them and therefore may affect their
compliance. Although the burden of treatment of an
EAI has previously been shown to be high in vespid
allergic patients, this has not yet been studied in food
allergic patients. Therefore we determined the overall
burden of treatment with the EAI in food allergic
patients as perceived by both patients themselves and
the parents of food allergic children. Furthermore, we
examined the outcome of food allergic reactions requir-
ing EAI use.
Methods
Food allergic patients of all ages prescribed an EAI,
attending an allergy clinic and the parents of food aller-
gic children (aged 0-17 years) were asked to complete
the following questionnaires: the Burden of Treatment
instrument (BoT), which was our primary outcome, the
Food Allergy Independent Measure questionnaire
(FAIM), EAI positive and negative statements, questions
concerning EAI prescription and use, and descriptive
questions.
Results
A total of 95 subjects were eligible for analysis. Two
subjects were excluded because they did not complete
the BoT. Of the remaining 93, 69 subjects (74%) were
(extremely) positive about the EAI. Only 3 subjects were
(slightly) negative about the EAI. In 31 patients
epinephrine injection was needed, because of at least
one allergic reaction. Out of these 31 patients, 11 did
not carry an EAI with them at the time of the food
allergic reaction. Only 2 patients (aged 16 and 21) were
administered an EAI dose by someone other than them-
selves or their parents. There were no deaths.
Conclusion
In contrast to vespid venom allergic patients, food aller-
gic patients and their parents are (extremely) positive
about carrying an EAI. Despite this, compliance with
carrying the device or using it when necessary seems to
be very low.
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